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Abstract
Recent analyses have identified positively selected loci that explain differences in immune responses, body forms, and
adaptations to extreme climates, but variants that describe adaptations in energy-balance regulation remain underexplored.
To identify variants that confer adaptations in energy-balance regulation, we explored the evolutionary history and
functional associations of candidate variants in 207 genes. We screened single nucleotide polymorphisms in genes that had
been associated with energy-balance regulation for unusual genetic patterns in human populations, followed by studying
associations among selected variants and serum levels of GIP, insulin, and C-peptide in pregnant women after an oral
glucose tolerance test. Our analysis indicated that 59 variants in CDKAL1, CYB5R4, GAD2, and PPARG are marked with
statistically significant signals of gene–environment interactions. Importantly, studies of serum hormone levels showed that
variants in CDKAL1 are associated with glucose-induced GIP and insulin responses (p,0.05). On the other hand, a GAD2
variant exhibited a significant association with glucose-induced C-peptide response. In addition, simulation analysis
indicated that a type 2 diabetes risk variant in CDKAL1 (rs7754840) was selected in East Asians ,6,900 years ago. Taken
together, these data indicated that variants in CDKAL1 and GAD2 were targets of prior environmental selection. Because the
selection of the CDKAL1 variant overlapped with the selection of a cluster of GIP variants in the same population ,11,800 to
2,000 years ago, we speculate that these regulatory genes at the human enteroinsular axis could be highly responsive to
environmental selection in recent human history.
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Introduction
Because of the recency of our common ancestry, it is well
accepted that the investigation of positively selected single
nucleotide polymorphisms (SNPs) in human populations may
explain arrays of phenotypic variation in humans. Indeed, recent
studies have identified hundreds of loci that exhibit evidences of
positive selection in human genomes, and uncovered variants that
describe variations in appearance, physiological adaptations, and
pathological responses to diseases, thereby providing a better
understanding of the molecular mechanisms that underlie these
selections [1,2,3,4]. However, genetic variants that confer adap-
tations in energy-balance regulation remain underexplored.
Because such variants were likely subject to selection pressures
that fluctuated over time, a moderate signal of selection could be
all that has remained as a clue to selection. Accordingly, we
screened gene region SNPs for unusual patterns in derived allele
frequency and linkage disequilibrium (LD) in genes that had been
associated with energy-balance regulation (i.e., past clinical
investigations, genome-wide association (GWA) studies, and
quantitative trait loci analyses) [5,6].
In these studies, we identified common 59 variants in five
genes—glucose-dependent insulinotropic polypeptide (GIP), Cdk5
regulatory associated protein 1-like 1 (CDKAL1), cytochrome b5
reductase 4 (CYB5R4), glutamate decarboxylase 2 (GAD2), and
peroxisome proliferator-activated receptor gamma (PPARG)—as
top metabolic modifier candidates. With the exception of GAD2
variant rs2236418, none of the candidate variants had been
implicated in earlier GWA studies although CDKAL1, CYB5R4,
and PPARG loci have been associated with diabetes- and/or
obesity-related traits [7,8,9,10,11,12]. It is possible that these
variants operate under physiological conditions that have not been
specifically investigated. Consistent with the hypothesis, our recent
studies have shown that three regulatory GIP variants were
positively selected ,8,100 (11,800 to 2,000) years ago, and are
associated with variations in glucose metabolism and glucose-
induced GIP response in pregnant women; moreover, a coding
GIP variant (rs2291725) affects the bioactivity of GIP [5,6].
To gain a better understanding of whether and how CDKAL1,
CYB5R4, GAD2, and PPARG variants contribute to adaptations
in energy-balance regulation, we further explored their evolution-
ary history and potential genotype–phenotype relationships in
humans.
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Materials and Methods
Ethics Statement and Patients
The study was approved by the institutional ethics committee
review board of Chang Gung Memorial Hospital Linkou Medical
Center, and was conducted in accordance with the guidelines in
The Declaration of Helsinki. A total of 131 unrelated healthy
women with normal pregnancy were recruited, and all patients
gave written informed consent to participate in the study. Related
patients (i.e., blood relatives) were excluded to ensure that the
observed associations were not due to confounding effects from
ancestry. The screening glucose challenge test for gestational
diabetes mellitus (GDM) was performed as previously described
[13]. Specifically, patients were given a 50-gram glucose solution
after overnight fasting at 23–29 weeks of gestation, and a blood
sample was taken at 1 hour after glucose intake. The mean age
and body mass index (BMI) of patients were 30.760.4 years and
25.460.3, respectively.
Genotyping
Genomic DNA samples of subjects were extracted and purified
from anticoagulated blood with the DNeasy Blood & Tissue Kit
(Qiagen). Genotyping of SNPs was performed using the Applied
Biosystems TaqMan Validated SNP Genotyping Assays. The
genotyping analysis had a .96% success rate and .99%
reproducibility.
Measurements and statistical analysis of circulatory levels
of GIP, insulin, and C-peptide
Blood samples were collected from patients 1 hr after admin-
istration of the oral glucose tolerance test (OGTT). Serum GIP,
insulin, and C-peptide levels were measured using specific ELISA
kits from Millipore, Mercodia, and Calbiotech, respectively.
Patients’ serum hormone profiles were analyzed by the x2 test,
the Student’s t-test, or linear regression analysis using GraphPad
Prism 5. All p-values were two-sided. The statistical significance
cutoff value was 0.05.
FST estimation and analysis of haplotypes
To identify adaptive SNPs, we screened for common gene
region variants that have divergent allele frequencies in HapMap
populations in 207 candidate genes [14]. To improve the odds of
identifying potential genotype–phenotype relationships, we fo-
cused on SNPs with a .30% minor allele frequency (MAF) in the
overall Eurasian (CEU [U.S. residents with northern and western
European ancestry] and ASN [pooled samples of Chinese from
Beijing [CHB] and Japanese from Tokyo [JPT]) populations. The
population genetic differentiation statistic FST among HapMap II
populations (i.e., CEU, ASN, and YRI [Yoruba from Ibadan]) was
computed using the PGEToolbox and SPSmart [15,16]. Putative
positive SNPs (i.e., those in the top 10%) were further analyzed
using pairwise population comparisons. The use of FST is
advantageous given that FST measures the proportion of total
genetic variance that is caused by differences among populations,
and does not require assumptions about the structure of human
populations and SNP ascertainment bias. In addition, LD blocks
and haplotype plots were analyzed using HaploView 4.1 [17].
Analysis of EHH and iHS statistics
We computed the extended haplotype homozygosity (EHH)
statistic for SNPs as previously described [18], and the EHH plots
were generated as described [4]. The EHH curve depicts the
decay of identity of haplotypes that carry alleles of a core SNP as a
function of distance between tested SNPs and the core SNP. When
an allele rises rapidly in frequency due to positive selection, it tends
to exhibit a high haplotype homozygosity that extends further than
expected in a neutral model. For the analysis of EHH decay,
haplotypes in the genomic region centered on select SNPs were
downloaded from the HapMap project website.
The integrated Haplotype Score (iHS) statistic detects whether
the area under the EHH curve for a selected allele is greater than
that for a neutral allele; it is a measure of recent positive selection
for variants that have not yet reached fixation [4]. To test whether
the observed iHS deviated significantly from the expected neutral
values, we used a coalescent model and generated 10,000
replicated haplotype sets using the coalescent simulator ms [19].
We adopted simulation parameters compatible with the sample
size of the population and the length of the genomic region that
was analyzed. The simulation was conditioned based on the same
recombination rate and the number of segregating sites within
tested regions.
Estimation of the age of selected allele
When a novel allele is positively selected, the allele and its linked
haplotype quickly rise to a high frequency. As the allele ages, the
length of the haplotype shortens over time due to recombination
and mutation. By modelling this process and measuring the decay
of the haplotype that carries the positively selected allele, the age of
the allele can be estimated [20]. The breakdown of the intactness
of the haplotype surrounding the selected allele was modeled using
a Poisson process as described earlier [21]. We obtained the
recombination map from the FTP site of the HapMap project
(ftp://ftp.ncbi.nlm.nih.gov/hapmap/recombination/). The rs775
4840 block consists of 70 SNPs, and is represented by 11 distinct
haplotypes in ASN; among which haplotypes 1, 6, and 8–10 carry
the derived allele C of rs7754840 (Fig. S1 in File S1, upper left
panel). Among these derived haplotypes, haplotype 1 with a
frequency of 0.259 is apparently the ancestral haplotype, from
which haplotypes 6 and 8–10—with frequencies of 0.029, 0.018,
0.015, and 0.015, respectively—were derived. The relative portion
of haplotype 1 (the ancestral haplotype) of all derived haplotypes is
P’ = 0.77.
The recombination map correlates the increment of physical
distance (Mb) with that of genetic distance (cM), which is derived
from the estimates of LD between HapMap SNPs [22]. We took
the mutation rate of the region u=1.6661026—based on the
haploid mutation rate of 1.161028 per base per generation [23]
and the probability of ascertaining HapMap SNPs, ,1023—for
the analysis. We assumed that the most common haplotype is the
ancestral haplotype and used P’ as an approximation of P.
The probability that a haplotype remains ancestral (i.e., that the
haplotype that carries the derived allele retains the status of high
frequency right after being selected) is P~e{G(rzm), where G is the
number of generations, r is the recombination rate per generation,
and m is the mutation rate per generation. For a given allele in the
derived haplotype, the haplotype-decay approach estimates the
number of generations G in terms of P (the probability that a given
haplotype does not change from its ancestor) [20,21].
In these analyses, the hypothetical demographic history
assumed that the ASN population is one panmictic population
that underwent a size reduction, followed by a period of constant
size. The population had an ancestral population size of N1, which
at time T2 instantaneously shrank to size N2. It remained constant
at size N2 until time T1, at which point it began expanding
exponentially until the present time. The population size at the
present time is N3 (i.e., the bottleneck model) [24].
Adaptive CDKAL1 Variants and Enteroinsular Response
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Results
Common 59 variants in CDKAL1, CYB5R4, GAD2, and
PPARG exhibit signals of selection
Studies of allele frequency of genic region SNPs in 207
candidate genes showed that, in addition to a cluster of 37 linked
GIP SNPs [6], common variants in the 59 proximate region of
CDKAL1 (rs9368197, position -1305 nt), CYB5R4 (rs1325471,
position -1695 nt), GAD2 (rs2236418, position -243nt), and
PPARG (rs2920502, position 2154 nt) exhibit highly skewed
population frequency in YRI, CEU, and ASN populations
(Table 1) [5,14]. The differences in derived allele frequency
between African (YRI) and Eurasian (i.e., CEU and ASN)
populations are in excess of 45–70%. For example, the derived
allele of PPARG rs2920502 increased from 2.6% in YRI to 35.7%
and 75.3% in CEU and ASN, respectively.
Analysis of FST statistics indicated that the frequency of the
derived CYB5R4 rs1325471 and GAD2 rs2236418 alleles in CEU,
and the frequency of the derived PPARG rs2920502 allele in ASN
are significantly different from those of YRI (Fig. 1; Table 1, p,
.05). Consistently, analysis of LD showed that the genomic regions
surrounding CDKAL1 rs9368197, GAD2 rs2236418, and PPARG
rs2920502 are characterized by long LD blocks in CEU and ASN
(Fig. S2, a-c in File S1). On the other hand, there is no appreciable
difference in LD block characteristics surrounding CYB5R4
rs1325471 among populations (Fig. S2d in File S1).
Measurements of the iHS statistic using coalescent simulations
in HapMap populations with a .10% derived allele frequency
showed that the derived CDKAL1 rs9368197 allele exhibits
significant EHH as compared to the ancestral allele in CEU and
ASN [4,18](Fig. 2a). The derived CDKAL1 rs9368197 allele-
associated haplotypes spanned approximately 150 kb, and the
frequency of two 90-kb-long derived haplotypes increased from
negligible in YRI to more than 53% in ASN (Fig. S3 in File S1,
upper panel). Likewise, the ancestral CYB5R4 rs1325471 allele
exhibited EHH in the YRI (Fig. 2b) whereas the ancestral and
derived alleles at rs2236418 of GAD2 exhibited EHH in CEU and
YRI, respectively (Fig. 2c). By contrast, rs2920502 of PPARG did
not exhibit appreciable EHH (Fig. 2d).
Because two intronic CDKAL1 variants (rs7754840 and
rs7756992) that are positioned close to rs9368197 have been
associated with type 2 diabetes and GDM in GWA studies
[25,26,27,28], we also analyzed the genetic patterns surrounding
these two variants (Fig. 2, e-f) [8,9,25,26]. Although the allele
frequencies of these variants were similar among HapMap
populations (Table 1), the derived allele of rs7754840, but not
rs7756992, exhibited a significant EHH in ASN (Fig. 2e).
Taken together, these data indicated that directional selection
resulted in the spread of the derived rs9368197 and rs7754840
alleles of CDKAL1, the ancestral rs2236418 allele of GAD2, and
the derived rs2920502 allele of PPARG in CEU and/or ASN
populations. On the other hand, the ancestral CYB5R4 rs1325471
allele and the derived GAD2 rs2236418 allele were selected in YRI
populations.
Common CDKAL1 variants rs9368197 and rs7754840
impart variations in glucose-induced insulin and GIP
response, respectively, in pregnant women
Because pregnancy represents a critical life stage that subjects
individuals to excessive metabolic load, and its success has a major
impact on reproductive fitness, we chose to analyze the
relationships among candidate variants and serum levels of GIP,
insulin, and C-peptide in pregnant women with the hope that it
would provide a sensitive model to uncover potential genotype–
phenotype relationships.
The frequency of candidate SNPs in the study population was
similar to that in ASN (Table 2), and was in the Hardy–Weinberg
equilibrium. Measurements of serum hormone levels showed that
levels of insulin, but not GIP or C-peptide, in patients who are
homozygous for the derived T allele of rs9368197 (i.e.,
CDKAL121305T/T, N=36) are significantly lower than those
carrying an ancestral rs9368197 allele (i.e., CDKAL121305G/G and
CDKAL121305G/T, N=89)(Fig. 3a; Table 2).
On the other hand, circulating GIP level in patients who are
homozygous for the ancestral G allele of rs7754840 (i.e.,
CDKAL1+12656G/G, N=54) was significantly lower than that of
those carrying a derived C allele (i.e., CDKAL1+126562C/C and
CDKAL1+126562G/C, N=65)(Fig. 3b; Table 2). Consistently, cir-
culating GIP level in patients who are homozygous for the derived
rs7754840 C allele (i.e., CDKAL1+12656C/C, N=15) was signifi-
cantly higher than that of those carrying an ancestral G allele (i.e.,
CDKAL1+126562G/G and CDKAL1+126562G/C, N=104)(Table 2).
In addition, linear regression analysis showed that the derived
CDKAL1 rs7754840 allele is associated with an enhanced glucose-
induced GIP response with an R2= 0.046 (p=0.018).
Furthermore, patients who are homozygous for the ancestral G
allele of GAD2 rs2236418 (GAD22243G/G, N=10) had a signifi-
cantly lower circulating level of C-peptide compared with those
carrying a derived A allele (GAD22243G/A and GAD22243A/A,
N=118)(Table 2). By contrast, the CBY5R4 and PPARG variants
did not have any significant relationship with serum insulin, GIP, or
C-peptide levels.
The type 2 diabetes/GDM risk variant of CDKAL1
rs7754840 emerged ,6,900 years ago in East Asians
To better understand putative events that led to the selection of
CDKAL1 variants, we estimated the age of selection based on
coalescent simulations [20,21,29,30]. Scanning of the LD map and
haplotype structures showed that informative SNPs surrounding
rs9368197 are too sparse for reliable age determination. On the
other hand, rs7754840 is located in a 151-kb-long LD block, bound
between rs6927481 and rs7741604 in the ASN (Fig. S1 in File S1,
upper left panel). Using the recombination map of the HapMap
project [14,22], we interpolated the values of accumulative
recombination at the positions of the two boundary SNPs of the
LD block and took the difference between the two values (0.0946
cM; i.e., 0.0946% chance of crossing over per generation) as the
recombination fraction for the region. This was translated into a
recombination rate r=9.4661024. Using theG~{ ln (P0)=(rzm)
equation, we obtained a generation estimate G=276. An estimated
generation time of 25 years indicated that the age of selection for
rs7754840 is ,6,900 years (Fig. 4).
Discussion
Based on an analysis of the evolutionary history of candidate
genes, we showed that common 59 variants in CDKAL1, CYB5R4,
GAD2, and PPARG as well as an intronic type 2 diabetes-
associated CDKAL1 variant exhibit non-neutral evolutionary
patterns. In addition, we found that CDKAL1 and GAD2 variants
are associated with glucose-induced insulin, GIP, or C-peptide
responses in pregnant women. Together with our earlier studies of
adaptive GIP variants [5,6], these data provided strong evidence
that the GIP-insulin-glucose axis is a hotspot for energy-balance
regulation-associated selection (Fig. 4) [31].
A wide spectrum of physiological differences among humans are
believed to be the result of positive selection of pre-existing
Adaptive CDKAL1 Variants and Enteroinsular Response
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variants and recent mutations that accumulated in response to
environmental or cultural changes [4,32]. Recent advances have
revealed adaptive SNPs that are associated with immune
responses, changes in body forms (e.g., that affect the pigmentation
of skin, hair, or eyes), and adaptations to extreme climates (e.g., the
selection of the EPAS1 gene in Tibetans) after humans spread to
various parts of the world in the last 50–60 thousand years
[1,2,3,4]. However, the identification of adaptive variants in
energy-balance regulation appeared to lag behind that of other
traits [33,34]. Earlier studies have shown that variants in TCF7L2
were positively selected, and were associated with BMI and levels
of ghrelin and leptin; however, no general enrichment of adaptive
variants in type 2 diabetes- and obesity-associated loci have been
found [35]. On the other hand, a study of SNPs in 40 major
human diseases indicated that a repertoire of type 2 diabetes risk
alleles have a tendency for directional selection in Eurasians [36].
It was speculated that this phenomenon could be associated with
culture changes; however, the importance of this ensemble of
‘‘selection signal’’ in humans remains to be investigated. Consis-
tent with these earlier studies, we found only a few SNPs that
exhibit signals of selection. The paucity of adaptive SNPs in
energy-balance regulation-associated genes could be due to
heterogeneity in intensity, form, or time of environmental
selection. In addition, recent culture changes that have subjected
humans to varying degrees of population growth, and cycles of
feast and famine could have made such variants retain only a
minimal ‘‘signature of selection’’ [37].
The finding that insulin levels are CDKAL1 variant-dependent
is not new. Intronic CDKAL1 variants rs7754840, rs7756992, and
rs10946398 have been associated with variations in insulin release,
pancreatic cell functions, hemoglobin A1C level, and/or response
to pancreatic KATP channel agonists [8,38,39] as well as type 2
diabetes, GDM, ulcerative colitis, Crohn’s disease, obesity, and/or
birth weight [9,25,26,28]. CDKAL1 has been shown to function
as a tRNA modification enzyme, and its activity is associated with
ATP generation and first-phase insulin secretion [40,41,42]. The
carriage of CDKAL1 risk variants may lead to lower insulin release
and impaired conversion of proinsulin to insulin in pancreatic beta
Figure 1. Differential distribution of CYB5R4, GAD2, and PPARG variants in human populations. The distribution of the FST for common
SNPs across the human genome and the FST for rs1325471, rs2236418, and rs2920502. For rs1325471 and rs2236418, FST estimations between YRI and
CEU (a-b) are shown on the x-axis. For rs2920502, comparisons between YRI and ASN (c) are shown on the x-axis. The black arrows indicate the
corresponding values of FST for the candidate variant. The y-axis represents the frequency of SNPs with a given FST estimate. Significant FST, which is
defined as higher than 95th percentile of FST of all common SNPs of HapMap populations, is indicated by an asterisk.
doi:10.1371/journal.pone.0105410.g001
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cells [43,44,45]. Although the effect of derived rs9368197 allele on
glucose-induced insulin response is similar to that reported for the
derived rs7754840 allele, the finding that the derived rs7754840
allele (i.e., C) is associated with an elevated GIP response is unique
because the same allele has been found to be associated with type 2
diabetes and reduced insulin secretion in earlier studies
[43,44,45,46]. These results suggest that the selection of derived
rs7754840 allele has opposite effects on insulin secretion and
glucose-induced GIP response. Because GIP’s normal function is
to stimulate insulin secretion, the adverse effect of derived
rs7754840 allele on insulin metabolism may be counteracted by
that on glucose-induced GIP response. Therefore, the reported
association between CDKAL1 variants and insulin metabolism
could be partially affected by the rs7754840-associated GIP
responses. In addition, the selection of the derived rs7754840 allele
in East Asians may explain part of the observed differences in
association strength between CDKAL1 and type 2 diabetes among
human populations [46]. In corroboration with this idea, recent
studies have reported that circulating GIP levels are highly familial
compared to circulating levels of glucose, insulin, or C-peptide
[47]. Future study of the effect of CDKAL1 on GIP synthesis/
secretion is needed to reveal whether CDKAL1 affects insulin
secretion and GIP metabolism via a similar mechanism.
In a recent investigation, we documented the strong selection of
a cluster of GIP variants in East Asians ,8,100 (11,800 to 2,000)
years ago [5,6]. It is surprising to find that the selection of
rs7754840 in CDKAL1 occurred in the same population at
approximately the same time period (i.e., ,6,900 years ago).
Because the selection of CDKAL1 and GIP variants overlapped,
and because GIP metabolism is highly regulated during pregnancy
[48], we speculate that the regulation of enteroinsular axis in
Eurasians was subject to strong environmental selection in recent
human history (Fig. 4). Because no significant selection of SNPs
was observed in other key enteroinsular regulatory genes—
including insulin, insulin receptor, glucagon-like peptide-1 (GLP-
1), GLP-1 receptor, glucagon, glucagon receptor, and GIP
receptor—CDKAL1 and GIP appear to be unique targets for
energy-balance regulation-associated selections.
Although it is impossible to discern which environmental forces
are responsible for the selection of CDKAL1 and GIP variants, the
Figure 2. Haplotype diversity surrounding CDKAL1, CYB5R4, and GAD2 variants is allele-dependent in select populations. Plots of iHS
over the distance between selected variants and neighboring SNPs at increasing distances in YRI, CEU, and ASN populations (rs9368197 [a],
rs1325471 [b], rs2236418 [c], rs292502 [d], rs7754840 [e], and rs7756992 [f]). A significant difference in EHH decay between the derived allele and the
ancestral allele is indicated by an asterisk. The candidate variant is positioned at the center of the plots.
doi:10.1371/journal.pone.0105410.g002
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selection of these variants during a period that heralded the
agriculture revolution and animal domestication (i.e., 10,000 to
4,000 years ago following the Neolithic period) suggests that the
selected CDKAL1 and GIP variants may have facilitated the
survival of their carriers in the face of changing subsistence culture.
As culture again shifted in modern society, some of these prior
advantageous adaptations (e.g., rs7754840) now may manifest as
risk factors for type 2 diabetes and GDM [25,27,28,44,45]. In
support of this view, recent studies have shown that minimal
changes in subsistence patterns could have profound effects on the
survival of individuals [49]. For example, it has been shown that
feeding mice human-relevant concentrations of added sugar (i.e.,
25% kcal from a mixture of fructose and glucose) is sufficient to
Figure 3. Genotypes of rs9368197 and rs7754840 in CDKAL1
impart a difference in glucose-induced insulin and GIP
response, respectively, after glucose challenge tests. a) Mea-
surements of serum insulin levels in patients during the 23rd to the 29th
weeks of pregnancy at 1 hr after the 50-gram glucose challenge test.
Levels of insulin in patients who were homozygous for the derived T
allele of rs9368197 (28.863.1 mU/L, N= 36) were significantly lower
than those of patients carrying the ancestral G allele (i.e., heterozygotes
and ancestral allele homozygotes, 42.863.7 mU/L, N=89). b) Measure-
ments of serum GIP levels in patients during the 23rd to the 29th weeks
of pregnancy at 1 hr after the 50-gram glucose challenge test.
Circulating levels of GIP in patients who were homozygous for the
ancestral G allele of rs7754840 (68.964.5 pg/ml, N = 54) were
significantly lower than were those of patients carrying a derived C
allele (i.e., heterozygotes and derived allele homozygotes, 82.864.5 pg/
ml, N=65). Serum hormone levels are presented as mean 6 SEM.
doi:10.1371/journal.pone.0105410.g003
Figure 4. CDKAL1 and GIP variants were selected in recent
human history. Schematic representation of the selection of multiple
CDKAL1 and GIP variants in ASN population [5,6]. The selection of
CDKAL1 and GIP variants appeared to occur independently within a
1,200-year time window in the last ten thousand years. The effects of
these selections on enteroinsular hormonal responses are indicated by
red arrows. The actions of hormones are indicated by black arrows.
doi:10.1371/journal.pone.0105410.g004
Table 2. Association between selected SNPs and hormonal responses after glucose challenge tests in pregnant women.
Gene (Candidate SNPs)
Frequency of alleles
(anc/der) Insulin (mU/L) GIP (pg/ml) C-peptide (ng/ml)
Mean ± SD [N] (p value)a
CDKAL1 (rs9368197) G 0.452/T 0.548 GG 38.5630.4 [24] (0.953) GG 82.3638.7 [25] (0.386) GG 2.0461.07 [25] (0.890)
GT 44.5638.8 [65] GT 75.2634.6 [59] GT 2.1961.18 [66]
TT 28.8±18.8 [36] (0.005)b TT 74.4634.0 [36] (0.674) TT 1.8760.71 [37] (0.111)
CYB5R4 (rs1325471) A 0.300/G 0.700 AA 35.8622.2 [13] (0.570) AA 81.9627.8 [14] (0.500) AA 2.0361.05 [14] (0.857)
AG 40.0633.3 [49] AG 75.1638.8 [46] AG 2.1161.06 [50]
GG 39.7634.5 [63] (0.917) GG 77.1634.8 [59] (0.952) GG 2.0761.07 [64] (0.890)
GAD2 (rs2236418) G 0.290/A 0.710 GG 48.3649.1 [10] (0.523) GG 72.2642.1 [9] (0.637) GG 1.45±0.79 [10] (0.027)c
GA 39.4629.1 [53] GA 80.2636.0 [51] GA 2.1261.13 [52]
AA 36.6630.8 [63] (0.456) AA 78.5641.7 [62] (0.940) AA 2.1261.00 [66] (0.571)
PPARG (rs2920502) C 0.222/G 0.778 CC 33.9624.4 [6] (0.601) CC 85.2646.4 [6] (0.666) CC 1.7061.50 [6] (0.785)
CG 43.8635.2 [44] CG 83.1638.9 [44] CG 2.2661.08 [45]
GG 37.2631.7 [76] (0.378) GG 72.3630.8 [71] (0.103) GG 2.0061.00 [77] (0.319)
CDKAL1 (rs7754840) G 0.669/C 0.331 GG 36.1629.7 [57] (0.394) GG 68.9±32.8 [54] (0.030)c GG 2.0260.95 [59] (0.606)
GC 42.0636.4 [52] GC 78.0634.4 [50] GC 2.1961.21 [53]
CC 37.6623.5 [15] (0.851) CC 98.9.±37.4 [15] (0.026)b CC 1.8460.83 [15] (0.485)
a p values of comparisons between a homozygous genotype, and those with a heterozygous or an opposite homozygous genotype (Student’s t-test).
b Significantly different from the averages of those with a heterozygous or a homozygous ancestral genotype. (p,0.05).
c Significantly different from the averages of those with a heterozygous or a homozygous derived genotype (p,0.05).
doi:10.1371/journal.pone.0105410.t002
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increase mortality and reduce fertility even though such treatments
have minimal effects on serum levels of cholesterol, fasting insulin,
fasting glucose, or fasting triglycerides. Although our hypothesis
cannot be falsified at the present time, future studies that consider
Neanderthal and Denisovan genomes may provide further insight
[50].
Studies of hormonal profiles have also uncovered an association
between GAD2 rs2236418 and glucose-induced C-peptide re-
sponse. Earlier studies have shown that polymorphisms of GAD2,
which encodes an enzyme that catalyzes the production of
gamma-aminobutyric acid (GABA), are associated with obesity,
BMI, and postabsorptive resting energy expenditure in selected
populations [10,51,52,53,54]. GABA originating within the islets
can evoke tonic currents, and decrease both insulin and glucagon
secretion [55,56]. In addition, the GABA signaling system has
been shown to be compromised in islets of type 2 diabetes patients
[57]. Therefore, the adaptive GAD2 variant could indirectly
contribute to variations in C-peptide, and perhaps insulin,
metabolism by affecting GABA synthesis. Future study of the
rs2236418-C-peptide relationship in other populations is needed
to have a better understanding of the regulation of enteroinsular
axis via neuronal signaling in humans.
Whereas CYB5R4 and PPARG variants were not associated
with the limited number of hormones that were analyzed, the
‘‘signals of selection’’ surrounding these variants warrant future
investigations under different conditions. Among them, rs2920502
and linked SNPs like rs2920500 could be particularly interesting
because PPARG has been associated with the development of type
2 diabetes, atherosclerosis, and cancer [7,58], and because PPAR-
c agonists (e.g., thiazolidinedione) have been used to treat type 2
diabetes [58]. Likewise, future studies in patients of African or
European origin may further reveal the role of selected CYB5R4
and GAD2 variants in the regulation of hormonal metabolism
because these variants were selected in CEU and/or YRI.
In conclusion, the present study showed that adaptive CDKAL1
variants could spread in Eurasians by contributing to alternative
insulin or GIP responses. Therefore, environmental or culture
changes in recent human history could have shaped the regulation
of our enteroinsular axis to a greater extent than what has
previously been assumed.
Supporting Information
File S1 Figure S1. Plots of the haplotype structure of
SNPs in a 151-kb LD block surrounding rs7754840 in the
HapMap II populations. The 70 SNPs between rs6927481
and rs7741604 (151-kb in length) were linked, and displayed a low
haplotype diversity in the ASN population (left upper panel). By
contrast, the same region in the YRI chromosomes (right panel)
exhibited a high complexity compared to the CEU and ASN
populations. The position of rs7754840 is indicated by a vertical
rectangular box. Figure S2. Variants in CDKAL1, GAD2,
and PPARG are highly linked in select human popula-
tions. Plots of the degree of LD between each pair of genotyped
SNPs in a 200-kb region surrounding the CDKAL1 (a), GAD2 (b),
PPARG (c), and CYB5R4 (d) loci in YRI, CEU, and ASN
populations. The color scheme was based on r2 values. Red areas
represent regions with a high degree of LD and a high likelihood
of odds (LOD) (D’ = 1, LOD scores .2). Blue areas represent
regions with low LOD (D’ = 1, LOD ,2). Figure S3.
Haplotype structures of SNPs neighboring rs9368197 in
the HapMap II populations. Plots of the haplotypes in a 200-
kb genomic region (20,541-20,741 kb on chromosome 6) sur-
rounding rs9368197 in CDKAL1 showed that ASN chromosomes
(upper panel) are characterized by a low-complexity structure
whereas YRI chromosomes exhibit extensive recombinations
(lower panel). The CEU chromosomes exhibited an intermediate
pattern of complexity (middle panel). A 90-kb region with
extensive haplotype homozygosity in ASN chromosomes is
indicated by a red rectangular box in each of the three haplotype
structure plots. The position of rs9368197 in each plot is indicated
by a blue arrow.
(PDF)
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